PMID: 9547332May 23, 1998Paper

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

The Journal of Experimental Medicine
P SchneiderJ Tschopp

Abstract

Human Fas ligand (L) (CD95L) and tumor necrosis factor (TNF)-alpha undergo metalloproteinase-mediated proteolytic processing in their extracellular domains resulting in the release of soluble trimeric ligands (soluble [s]FasL, sTNF-alpha) which, in the case of sFasL, is thought to be implicated in diseases such as hepatitis and AIDS. Here we show that the processing of sFasL occurs between Ser126 and Leu127. The apoptotic-inducing capacity of naturally processed sFasL was reduced by >1,000-fold compared with membrane-bound FasL, and injection of high doses of recombinant sFasL in mice did not induce liver failure. However, soluble FasL retained its capacity to interact with Fas, and restoration of its cytotoxic activity was achieved both in vitro and in vivo with the addition of cross-linking antibodies. Similarly, the marginal apoptotic activity of recombinant soluble TNF-related apoptosis-inducing ligand (sTRAIL), another member of the TNF ligand family, was greatly increased upon cross-linking. These results indicate that the mere trimerization of the Fas and TRAIL receptors may not be sufficient to trigger death signals. Thus, the observation that sFasL is less cytotoxic than membrane-bound FasL may explain why in certain t...Continue Reading

References

Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M LewisD V Goeddel
Jun 1, 1980·The Biochemical Journal·J K WrightJ Engel
Sep 1, 1995·International Immunology·M HahneJ Tschopp
Dec 1, 1995·The Journal of Experimental Medicine·N KayagakiH Yagita
Nov 17, 1995·Science·T S GriffithT A Ferguson
Feb 2, 1995·Nature·J DheinP H Krammer
Mar 10, 1995·Science·S Nagata, P Golstein
Aug 1, 1995·European Journal of Immunology·A Rensing-EhlA Fontana
Aug 1, 1995·European Journal of Immunology·S M MarianiP H Krammer
Oct 19, 1995·Nature·D BellgrauR C Duke
Nov 1, 1995·The Journal of Experimental Medicine·P R GalleL Runkel
Aug 26, 1993·Nature·J OgasawaraS Nagata
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J H RussellR Wang
Mar 1, 1996·Nature Medicine·M TanakaS Nagata
Jun 14, 1996·Journal of Immunological Methods·S M MarianiP H Krammer
Jun 1, 1996·Current Biology : CB·S A MarstersA Ashkenazi
Feb 7, 1997·Cell·S Nagata
Jul 25, 1997·The Journal of Biological Chemistry·P SchneiderJ Tschopp
Aug 1, 1997·Trends in Biochemical Sciences·D W Nicholson, N A Thornberry
Oct 6, 1997·The EMBO Journal·H WalczakC T Rauch
Oct 7, 1997·The Journal of Experimental Medicine·M A Degli-EspostiC A Smith
Dec 31, 1997·FEBS Letters·P SchneiderJ Tschopp
Feb 21, 1998·Current Biology : CB·S A MarstersA Ashkenazi
Jan 24, 1998·The Journal of Biological Chemistry·Y ChicheporticheJ L Browning
Jan 14, 1998·Nature Medicine·M TanakaS Nagata
Jan 1, 1995·Trends in Cell Biology·J C AmeisenF De Bels

❮ Previous
Next ❯

Citations

Jun 26, 1999·European Journal of Immunology·P SchneiderH Wajant
Jan 5, 2002·European Journal of Immunology·Philip G Hargreaves, Aymen Al-Shamkhani
Jan 10, 2002·Biochemical and Biophysical Research Communications·P AugsteinE Salzsieder
Aug 23, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Constance Assohou-LutyHarald Wajant
Jan 22, 2005·Cancer Immunology, Immunotherapy : CII·Yuru MengDavid A Fishman
Jun 27, 2007·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·D F IerardiS Cavalheiro
Aug 9, 2007·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Jong-Beom ParkK Daniel Riew
Mar 29, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M Guzmán-FulgencioS Resino
Dec 1, 2006·Apoptosis : an International Journal on Programmed Cell Death·Kazuhisa NakanoYoshiya Tanaka
Apr 26, 2011·Apoptosis : an International Journal on Programmed Cell Death·Kinga Musiał, Danuta Zwolińska
Mar 24, 2005·Cancer Metastasis Reviews·Theresa L Whiteside
Jan 24, 2004·Brain Research. Brain Research Reviews·Chulhee Choi, Etty N Benveniste
Aug 10, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Sukanya RaghuramanGopalan Sridharan
Dec 5, 2002·Archives of Biochemistry and Biophysics·Tracy Vargo-GogolaLynn M Matrisian
Oct 14, 2003·Biochemical Pharmacology·Andreas LinkermannOttmar Janssen
Dec 4, 2001·Journal of Immunological Methods·Nina Beate LiabakkTerje Espevik
Mar 22, 2000·Journal of Immunological Methods·N HollerP Schneider
Jun 24, 2003·Journal of Molecular and Cellular Cardiology·Taro DateCanwen Jiang
May 10, 2003·Life Sciences·Po-Lin Kuo, Chun-Ching Lin
May 17, 2000·Pharmaceutica acta Helvetiae·P Schneider, J Tschopp
Sep 23, 2003·Cellular Signalling·James F Curtin, Thomas G Cotter
Apr 27, 2000·Current Opinion in Immunology·G Screaton, X N Xu
Oct 31, 1998·Current Opinion in Immunology·J TschoppM Thome

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.